Skip to main content

Table 5 Patterns of relapse of all patients who received h-R3/RT or CDDP/RT. (N = 104)

From: A retrospective paired study: efficacy and toxicity of nimotuzumab versus cisplatin concurrent with radiotherapy in nasopharyngeal carcinoma

  h-R3/RT (N = 52) CDDP/RT (N = 52)
Relapse and metastasis [n (%)] [n (%)]
Local recurrence 2 (3.9%) 2 (3.9%)
Hepatic metastases 2 (3.9%) 3 (5.8%)
Lung metastasis 1 (1.9%) 3 (5.8%)
Bone metastasis 1 (1.9%) 2 (3.9%)
  1. Abbreviations: RT radiotherapy, h-R3/RT nimotuzumab and radiotherapy, CDDP/RT cisplatin and radiotherapy